Osmania General Hospital

A Phase III, Open-Label, Single-Arm, Multicentric Study of Tildrakizumab in Indian Patients with Moderate-to-Severe Plaque Psoriasis

Moderate-to-severe plaque psoriasis is a chronic inflammatory disease linked to significant morbidity and reduced quality of life (QoL). Prospective data on interleukin-23 (IL-23) inhibitors in Indian patients remain limited. This phase III, open-label, multicentre, single-arm br...

Evaluation of Advanced Lipid Biomarkers and Novel Atherogenic Indices in Predicting Coronary Artery Disease Severity Among Very Premature ACS Patients

Introduction Premature coronary artery disease occurs in men under 55 and women under 65 years, with very premature cases appearing as early as 45. It can affect patients with normal lipid levels, and the absence of specific guidelines for the Indian population leads to inadequat...